Cellular Biomedicine Group, Inc. Aktie
Aktien
A1JUHH
US15117P1021
CBMG
Biotechnologie
Manager | Titel | Alter | Seit |
---|---|---|---|
Bi Zuo Liu
CEO | Chief Executive Officer | 60 | 06.02.13 |
Yi Hong Yao
CTO | Chief Tech/Sci/R&D Officer | 57 | 01.08.15 |
Stephan Grupp
PRN | Corporate Officer/Principal | - | - |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Edward Schafer
BRD | Director/Board Member | 77 | 12.10.19 |
Bi Zuo Liu
CEO | Chief Executive Officer | 60 | 06.02.13 |
Chun Kwok Au
BRD | Director/Board Member | 51 | 11.11.14 |
% 1. Jan. | Kap. | |
---|---|---|
+1,51 % | 42,75 Mrd. | |
+8,57 % | 41,34 Mrd. | |
+49,22 % | 41,61 Mrd. | |
-12,36 % | 26,59 Mrd. | |
+8,92 % | 25,49 Mrd. | |
-25,13 % | 18,12 Mrd. | |
+29,17 % | 12,24 Mrd. | |
-3,12 % | 11,76 Mrd. | |
+6,35 % | 11 Mrd. |